Organization chart

Diverse ties with individuals and companies will strengthen our business foundation and expand our activities.

In addition to the Scientific Advisory Board and Senior Advisors that support new drug development from the standpoint of experts, we will work with external partner companies to build a more thorough system for the launch of new drugs.

Organizational Chart (as of November 4, 2024)